Toll-Free: 0800 CORDBANK Questions? Request more information here.

Research & Developments

Skills Dads need to know

Skills Dads need to know

    Being a modern dad isn’t easy, as it turns out the job requires a wide array of different skills, according to a new survey. The research, commissioned by Braun ahead of Father’s Day, found that modern dads must know a multitude of information and topics – including how to navigate social media and the…

Read More

The age of ‘the grands’.

The age of ‘the grands’.

The age of ‘the grands’. You can’t miss them. Grandparents are everywhere: on the school run, in the playground, waiting in the doctor’s surgery, reading to children in school, manoeuvring buggies onto trains and buses, standing loyally in goal. As hands-on providers of childcare, “the grands” have never been more visible or more indispensable to working parents. It’s…

Read More

Can hearing loss in children be treated with stem cells?

Can hearing loss in children be treated with stem cells?

A study by a local husband and wife team is showing promising results for the use of umbilical cord blood to treat children with hearing loss. In their clinical trial, Linda Baumgartner, a listening and spoken language specialist at Clarke School for Hearing and Speech, and her husband, Dr. James Baumgartner, surgical director of Comprehensive…

Read More

Sarah’s Story–Treating Autism with Stem Cells

Sarah’s Story–Treating Autism with Stem Cells

In 2010, Anna and her husband decided to bank their son, Ryan’s, cord blood with New England Cord Blood Bank, Inc. (NECBB). Two years later, when their daughter Sarah was born, they opted to save her cord blood as well. Later, when Sarah was diagnosed with Autism, Anna thought about the possibility of using cord blood stem…

Read More

Can cord blood therapy help arthritis patients?

Clinical and laboratory results document psoriatic arthritis in a 56-year old patient. The symptoms did not resolve with standard treatments (nonsteroidal anti-inflammatory drugs, steroids and methotrexate). TNF-alpha inhibitors (certolizumab pegol and adalimumab) were added to the treatment regime, with some adverse effects. A trial of human umbilical cord stem cell therapy was then initiated. The…

Read More

New developments in stem cell treatment for eye diseases

  Stem cells are undifferentiated cells which have the ability to self-renew and differentiate into mature cells. They are highly proliferative, implying that an unlimited number of mature cells can be generated from a given stem cell source. On this basis, stem cell replacement therapy has been evaluated in recent years as an alternative for…

Read More

Major hospital joins pioneering cord blood cardiac treatment study

LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles is announcing participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect that leaves them with half a heart. “It is very exciting that Children’s Hospital Los Angeles has joined…

Read More

Improvement for MS patients undergoing stem cell therapy

  To investigate the clinical efficacy and safety of umbilical cord mesenchymal stem cell (UCMSC) transplantation for treating multiple sclerosis (MS), the patients with MS were recruited and treated with UCMSC. The procedure of preparing UCMSC was in accordance with the standards formulated by the International Society for Cell Biology. Cell surface markers, multiple differentiation…

Read More

Can cord blood stem cells help stroke patients?

Stroke is a major cause of death and long-term disability, affecting one in six people worldwide. The only currently available approved pharmacological treatment for ischemic stroke is tissue plasminogen activator; however, relatively few patients are eligible for this therapy. We hypothesized that intravenous (IV) infusion of banked unrelated allogeneic umbilical cord blood (UCB) would improve…

Read More

Duke University gets green light to offer more cord blood therapy

Duke University Medical Center has received permission from the FDA to offer cord blood therapy for conditions like autism spectrum disorder and cerebral palsy under an expanded access clinical trial. This protocol establishes an umbrella clinical trial NCT03327467 registered on 31 Oct. 2017 which enables children who have these neurological disorders to receive therapy with…

Read More
Call Now Button